Skip to main content
. 2018 Jun 19;9(47):28486–28499. doi: 10.18632/oncotarget.25503

Figure 2. Treatment of a Krebs-2 solid tumor (summer 2016).

Figure 2

(A) A schedule of injections. (B) Dynamics of changes in the tumor size and number of animals with the tumor. Data for the following animal groups treated according to the schedule (A) are shown: control, untreated; CP, CP-only; CP+DNAmix, intratumoral injections of CP and DNA; DNA preparation was a mixture of equal amounts of native human DNA and salmon DNA (3 : 5 = cross-linked : native). CP+hDNA, injections of CP and human DNA; CP+ssDNAmix, injections of CP and salmon sperm DNA (3 : 5 = cross-linked : native). CP+DNAmix another leg, injections of CP and DNAmix in the contralateral tumor-free leg.